Chemed Corporation (ETR:CXM)
Germany · Delayed Price · Currency is EUR | Market Cap | 5.80B +3.9% |
| Revenue (ttm) | 2.27B +3.3% |
| Net Income | 240.70M -5.3% |
| EPS | 17.43 +2.2% |
| Shares Out | n/a |
| PE Ratio | 24.10 |
| Forward PE | 19.50 |
| Dividend | 2.15 (0.49%) |
| Ex-Dividend Date | Aug 17, 2026 |
| Volume | 2 |
| Open | 448.00 |
| Previous Close | 442.00 |
| Day's Range | 442.00 - 448.00 |
| 52-Week Range | 358.00 - 478.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides dire... [Read more]
Financial Performance
In 2025, Chemed's revenue was $2.53 billion, an increase of 4.06% compared to the previous year's $2.43 billion. Earnings were $265.24 million, a decrease of -12.17%.
Financial numbers in USD Financial StatementsNews
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on...
Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says
The Capitol Forum stated in a post to X: “Chemed (CHE): Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed…
Chemed boosts quarterly dividend to 70c from 60c per share
Chemed (CHE) Corporation announced that the board of directors has declared a quarterly cash dividend of 70c per share on the company’s capital stock, payable on September 3 to shareholders…
Chemed Corporation Declares Quarterly Dividend of 70 Cents
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's ca...
Chemed price target raised to $590 from $500 at Oppenheimer
Oppenheimer raised the firm’s price target on Chemed (CHE) to $590 from $500 and keeps an Outperform rating on the shares following quarterly results. Overall, Vitas continues to shoulder the…
Chemed price target raised to $548 from $436 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on Chemed (CHE) to $548 from $436 and keeps a Sector Perform rating on the shares. The company delivered another…
Chemed Earnings Call Transcript: Q2 2026
VITAS delivered strong Q2 2026 results, driving higher revenue and margins, while Roto-Rooter maintained stable performance despite increased marketing costs. Full-year guidance was raised for VITAS, with robust cash flow supporting acquisitions and share repurchases.
Chemed Earnings release: Q2 2026
Chemed released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Chemed Slides: Q2 2026
Chemed has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Chemed Quarterly report: Q2 2026
Chemed has published its Q2 2026 quarterly earnings report on July 29, 2026.
Chemed reports Q2 adjusted EPS $6.06, consensus $5.60
Reports Q2 revenue $673.25M, consensus $665.04M.
Chemed raises FY adjusted EPS view to $25-$25.75 from $24-$24.75
Consensus is $24.34. The revised guidance assumes an effective corporate tax rate on adjusted earnings of 24.5% and a diluted share count of 13.5 million shares.
Chemed Reports Second-Quarter 2026 Results
CINCINNATI, July 28, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto...
Chemed price target raised to $510 from $450 at BofA
BofA analyst Joanna Gajuk raised the firm’s price target on Chemed (CHE) to $510 from $450 and keeps a Neutral rating on the shares. Accelerating Google search interest for plumbing…
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
CINCINNATI, July 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2026, on Tuesday, July 28, 202...
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
CINCINNATI, June 08, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired a formerly independent Roto...
Chemed Transcript: RBC Capital Markets Global Healthcare Conference 2026
Admissions and census are growing ahead of expectations, driven by a balanced mix of hospital and non-hospital sources and rapid ramp-up in new Florida markets. CAP mitigation strategies are effective, with new inpatient units and labor expansion supporting future growth. Regulatory scrutiny is welcomed, with a focus on targeted anti-fraud efforts.
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2026 annual stockholders' meeting.
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May...
Chemed Transcript: Bank of America Global Healthcare Conference 2026
Census and margin outlooks were raised for the hospice segment, supported by improved referral management and regulatory changes. Expansion continues via de novo growth and selective acquisitions, while digital marketing and operational efficiencies drive recovery in the non-healthcare segment.
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2026 Health Care Conference on Tuesday,...
Chemed price target raised to $436 from $422 at RBC Capital
RBC Capital raised the firm’s price target on Chemed (CHE) to $436 from $422 and keeps a Sector Perform rating on the shares. Shares rallied over 10% on Friday following…
Chemed Earnings Call Transcript: Q1 2026
VITAS delivered strong Q1 2026 results, raising full-year guidance for ADC, revenue, and EPS, while Roto-Rooter showed early signs of recovery despite higher marketing costs and weather disruptions. Franchise acquisitions and improved collections supported growth.
Chemed Earnings release: Q1 2026
Chemed released its Q1 2026 earnings on April 24, 2026, summarizing the period's financial results.